Ipilimumab - PDFSEARCH.IO - Document Search Engine

Ipilimumab
Results: 93

#	Item
21	Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medicines Consortium. The detailed advice for each medicine that Add to Reading List Source URL: www.scottishmedicines.org.uk Language: English Bristol-Myers Squibb Cancer treatments Ribbon symbolism Trastuzumab Ipilimumab Breast cancer Pertuzumab Scottish Medicines Consortium Saxagliptin Medicine Chemistry Pharmacology
22	SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medici Add to Reading List Source URL: www.scottishmedicines.org.uk Language: English Ipilimumab Collagenase clostridium histolyticum Ribbon symbolism Bevacizumab Clostridium histolyticum Melanoma Metastatic breast cancer Collagenase Everolimus Medicine Oncology Bristol-Myers Squibb
23	MD Anderson, MedImmune join forces on immunotherapy Friday, March 14, 2014 Jim Allison, Ph.D., is executive director of the immunotherapy platform. MD Anderson and MedImmune, the global biologics research and development Add to Reading List Source URL: www.mdanderson.org Language: English - Date: 2015-05-09 06:45:52 Cancer organizations Immunotherapy Melanoma Cancer immunotherapy Cancer research Ipilimumab Prostate cancer Cancer vaccine James L. Gulley Medicine Cancer treatments Immunology
24	Bristol-Myers Squibb and MD Anderson Cancer Center Announce Novel Research Collaboration MD Anderson News ReleaseBristol-Myers Squibb Company (NYSE: BMY) and The University of Texas MD Anderson Cancer Center to Add to Reading List Source URL: www.mdanderson.org Language: English - Date: 2015-05-09 06:46:30 Immunology Ipilimumab Melanoma Immunotherapy Targeted therapy CTLA-4 Oncology Management of cancer Tremelimumab Medicine Bristol-Myers Squibb Cancer treatments
25	Collaboration with Johnson & Johnson Innovation announced Tuesday, January 21, 2014 MD Anderson will collaborate with Johnson & Johnson Innovation, LLC, and its affiliate Janssen Biotech Inc., to develop immunology-based Add to Reading List Source URL: www.mdanderson.org Language: English - Date: 2015-05-09 06:44:39 Immunotherapy Cancer organizations Melanoma Ipilimumab Cancer immunotherapy Management of cancer University of Texas MD Anderson Cancer Center James L. Gulley Cancer vaccine Medicine Cancer treatments Immunology
26	Interim Financial Report for the Period January 1 to March 31, 2015 Add to Reading List Source URL: www.bavarian-nordic.com Language: English - Date: 2015-05-05 01:45:46 Cancer vaccines Biology Microbiology Virology Ipilimumab Vaccination schedule Bacillus Calmette-Guérin GeoVax Medicine Vaccines Vaccination
27	Strong grasp of immune response dynamics will enhance checkpoint blockade Add to Reading List Source URL: medicalxpress.com Language: English - Date: 2015-05-03 06:19:38 Immunology T cells PD-1 PD-L1 Ipilimumab Immunotherapy Cancer immunotherapy Melanoma CTLA-4 Medicine Biology Immune system
28	Researchers offer update on immunotherapy based cancer fighting drugs Add to Reading List Source URL: medicalxpress.com Language: English - Date: 2015-05-05 06:17:01 Oncology Immunotherapy Cancer immunotherapy Ipilimumab Cancer immunology Chemotherapy Immune system PD-1 Cancer vaccine Medicine Immunology Cancer treatments
29	Bristol-Myers earnings jump 27 percent, but stock falls Add to Reading List Source URL: medicalxpress.com Language: English - Date: 2015-05-15 20:57:34 Pharmaceutical sciences Ipilimumab Gilead Sciences Melanoma FactSet Research Systems Food and Drug Administration Aripiprazole Medicine in China Bristol-Myers Squibb Medicine Chemistry
30	Microsoft WordDabrafenib GSK PSD March 13 final...docx Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2014-10-01 21:56:23 Melanoma Organochlorides Organofluorides Sulfonamides Vemurafenib BRAF Ipilimumab Dacarbazine End point of clinical trials Medicine Chemistry Oncology

UPDATE